What is the NBY stock price prediction for next 2 weeks?

According to our price prediction algorithm,NovaBay Pharmaceuticals, Inc. (NBY) price will be around $1.20 in the next 2 weeks. This means it will decrease by -35.97872340425531 from the last closing price. This prediction may vary from other time period filters for NBY stock.

What can be the highest Possible price of NBY stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, NBY can achieve the highest price of $1.74 which is -7.576466456901203 lower than last closing price. This prediction may vary from other time period filters for NBY stock.

What can be the lowest Possible price of NBY stock in next 2 weeks?

As per the forecast and algorithmic analysis, NBY stock price can be as low as $0.64 which is -65.84147701377451 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for NBY stock.

Will NBY stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that NBY stock will lose-35.97872340425531 in the next 2 weeks. This prediction may vary from other time period filters for NBY stock.

What is NBY stock last closing price?

Last closing price of NBY stock was $1.95.

What is NBY stock price prediction?

NBY stock price prediction means predicting the future closing prices of NBY stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of NBY stock in a certain time period.

How we predict NBY stock future prices?

If you are searching for NBY stock forecast, analysis or price prediction, then you might be wondering what NovaBay Pharmaceuticals, Inc. (NBY) will do in the future. Our NBY price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This NBY price prediction will likely answer most of your questions.

How frequent we update NBY stock predictions?

We are updating the forecasts for the NBY stock on daily basis.

Is using ML forecasting for NBY stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for NBY stock same for all the time periods?

No, the prediction for NBY stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

NovaBay Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.950%Since 2 Weeks

Predicted Price$1.20-35.98%For 2 Weeks

Upper Predicted Price$1.74-7.58%For 2 Weeks

Lower Predicted Price$0.64-65.84%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of NBY will decline by -35.98% over the next 2 Weeks and hit $1.20 by Thursday, April 16, 2026. In that time frame, NBY's share price is expected to range between $0.64 and $1.74.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 16, 2026	0.00	0.54	1.13
Apr 15, 2026	0.00	0.53	1.16
Apr 14, 2026	0.00	0.58	1.20
Apr 13, 2026	0.00	0.60	1.20
Apr 10, 2026	0.00	0.59	1.20
Apr 9, 2026	0.16	0.77	1.43
Apr 8, 2026	0.14	0.76	1.35
Apr 7, 2026	0.24	0.82	1.40
Apr 6, 2026	0.27	0.84	1.48
Apr 3, 2026	0.22	0.83	1.44

NBY shares fell -3.59% in Monday, April 6, 2026's trading session, dropping from a previous close of $1.95 to move at $1.88. The stock demonstrated notable intraday movement (see NBY's key stats for a full breakdown), fluctuating between $1.66 and $2.13, a +28.63% trading range. While recent weeks have seen some volatility, NBY has managed to secure a +54.10% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 623.93K shares changing hands, 412.46K more than the previous session. This amounted to $1.17M in total market activity.

Will NBY Continue Its Downward Trend?

According to analyst ratings and projections for NBY, NovaBay Pharmaceuticals, Inc. shares are anticipated to decrease by -66.96%, potentially reaching $1.13 per share by April 16, 2026. Short-term technical indicators for NBY currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the NBY stock forecast, now is not the best time to buy NBY stock because its current trading price is +248.15% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NBY covering social and institutional perspectives.

NBY Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into NBY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.51% to 40.33%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 45.24%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.25%, maintains a neutral outlook for the long term. Insights into NBY's shareholder base show how institutional investors are positioning themselves during these momentum shifts

NovaBay Pharmaceuticals, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, NovaBay Pharmaceuticals, Inc. (NBY) is positioned to show a strong performance in May 2026. The price is predicted to move between $19.90 and $30.54, settling at an average of $24.80. This could translate to a +1,219.15% gain.

June 2026

Based on current market signals, NovaBay Pharmaceuticals, Inc. is projected to trend june 2026. We forecast a trading range from $12.84 to $37.14, with a likely average price of $28.70. Investors could expect a potential return of +1,426.60%.

July 2026

Our predictive algorithms indicate NovaBay Pharmaceuticals, Inc. stock may see a shift in July 2026. The expected range spans $5.48–$23.75, with an average target of $12.11. This represents a positive outlook and a possible gain of +544.15%.

August 2026

Analyzing established trends, NovaBay Pharmaceuticals, Inc. looks set to move in August 2026. Projections place the stock between $20.16 and $36.99, averaging around $28.99. This suggests a +1,442.02% gain from current levels.

September 2026

Market indicators suggest NovaBay Pharmaceuticals, Inc. could experience notable changes during September 2026. Prices could fluctuate within $20.27 to $36.44, with a midpoint forecast of $27.82. The stock might deliver a +1,379.79% gain.

October 2026

Forecasting for October 2026, models estimate that NovaBay Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $25.54 and $72.61, averaging $50.41. This signals a positive trajectory with potential returns around +2,581.38%.

November 2026

According to our latest forecast models, NovaBay Pharmaceuticals, Inc. (NBY) is positioned to show a strong performance in November 2026. The price is predicted to move between $34.00 and $81.98, settling at an average of $62.65. This could translate to a +3,232.45% gain.

December 2026

Based on current market signals, NovaBay Pharmaceuticals, Inc. is projected to trend december 2026. We forecast a trading range from $28.12 to $62.51, with a likely average price of $39.93. Investors could expect a potential return of +2,023.94%.

January 2027

Our predictive algorithms indicate NovaBay Pharmaceuticals, Inc. stock may see a shift in January 2027. The expected range spans $47.29–$73.69, with an average target of $62.30. This represents a positive outlook and a possible gain of +3,213.83%.

February 2027

Analyzing established trends, NovaBay Pharmaceuticals, Inc. looks set to move in February 2027. Projections place the stock between $21.39 and $57.87, averaging around $36.40. This suggests a +1,836.17% gain from current levels.

March 2027

Market indicators suggest NovaBay Pharmaceuticals, Inc. could experience notable changes during March 2027. Prices could fluctuate within $28.14 to $120.42, with a midpoint forecast of $75.99. The stock might deliver a +3,942.02% gain.

April 2027

Forecasting for April 2027, models estimate that NovaBay Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $88.46 and $121.34, averaging $111.42. This signals a positive trajectory with potential returns around +5,826.60%.

NBY's history of dividends and stock splits also plays a role in long-term investor confidence.